Futura Medical (FUM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 0.000p
   
  • Closing Price Chg:
      0.000p
  • 52 Week High: 40.00
  • 52 Week Low: 8.00
  • Currency: UK Pounds
  • Shares Issued: 303.83m
  • Volume: 0
  • RiskGrade: 479

Futura Medical Overview

FUTURA MEDICAL is a research and development pharmaceutical company developing a portfolio of innovative products based on our proprietary, transdermal DermaSys® technology.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn 8.9% -71.3%
ROCE n/a  
Latest F'cast
P/E 21.3 15.7
PEG n/a 0.4
Pr/Revenue 2.0 2.3
Pr/Book 3.1  
Latest F'cast
Revenue 349.1% -63.8%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Futura Medical Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 n/a (2.93) (0.99)p n/a n/a n/a n/a 0.0%
31-Dec-21 n/a (5.87) (1.83)p n/a n/a n/a n/a 0.0%
31-Dec-22 n/a (6.87) (2.03)p n/a n/a n/a n/a 0.0%
31-Dec-23 3.10 (6.89) (2.21)p n/a n/a n/a n/a 0.0%
31-Dec-24 13.93 1.29 0.43p 73.6 n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Futura Medical Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 5.04 (3.59) (1.14)p n/a n/a n/a n/a 0.0%
31-Dec-26 5.10 (2.58) (0.75)p n/a n/a n/a n/a 0.0%
31-Dec-27 6.57 (0.69) (0.22)p n/a n/a n/a n/a 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Futura Medical Company Announcements

Block Listing Six Monthly Return 02-Jun-2025 15:15 RNS
Notice of AGM and availability of Annual Report 27-May-2025 07:00 RNS
Change of Broker 24-Apr-2025 07:00 RNS

Latest Futura Medical Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Futura Medical Market Data

Currency UK Pounds
Share Price 9.00p
Closing Price Change 0.000p
% Change 0.00 %
52 Week High 40.00
52 Week Low 8.00
Volume 0
Shares Issued 303.83m
RiskGrade 479

Futura Medical Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
30.82% below the market average30.82% below the market average30.82% below the market average30.82% below the market average30.82% below the market average
91.30% above the sector average91.30% above the sector average91.30% above the sector average91.30% above the sector average91.30% above the sector average
Price Trend
93.97% below the market average93.97% below the market average93.97% below the market average93.97% below the market average93.97% below the market average
86.96% below the sector average86.96% below the sector average86.96% below the sector average86.96% below the sector average86.96% below the sector average
Income Not Available
Growth
22.82% above the market average22.82% above the market average22.82% above the market average22.82% above the market average22.82% above the market average
20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Futura Medical Dividends

No dividends found

Trades for 02-Jun-2025

Time Volume / Share Price
14:59 3,000 @ 9.48p
14:59 10,536 @ 9.44p
14:46 45,725 @ 9.46p
14:41 19,538 @ 9.45p
14:38 53,336 @ 9.37p

Futura Medical Key Personnel

CEO James Henry Barder
Finance Director Angela Hildreth

Top of Page